Benjamin J. Hindson, See Remarks at 10x Genomics, Inc. (TXG), sold 13,940 shares at $62.36 ($867K) on 2023-08-01, disclosed to the SEC on 2023-08-03.
Scheduled sale ($867k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.77 | 1,727 | $107K | 12.3% |
| 2 | $61.77 | 1,727 | $107K | 12.3% |
| 3 | $62.36 | 5,243 | $327K | 37.7% |
| 4 | $62.36 | 5,243 | $327K | 37.7% |
| Total | $62.21 avg | 13,940 | $867K | 100% |
| Filing → |
| TXG | SELL | 2026-02-25 | $145K | — | Filing → |
| TXG | SELL | 2025-11-25 | $157K | — | Filing → |
| TXG | SELL | 2025-08-26 | $206K | — | Filing → |